Search

Your search keyword '"Kashin-Beck Disease physiopathology"' showing total 24 results

Search Constraints

Start Over You searched for: Descriptor "Kashin-Beck Disease physiopathology" Remove constraint Descriptor: "Kashin-Beck Disease physiopathology"
24 results on '"Kashin-Beck Disease physiopathology"'

Search Results

1. T-2 toxin induces articular cartilage damage by increasing the expression of MMP-13 via the TGF-β receptor pathway.

2. Reduction of Smad2 caused by oxidative stress leads to necrotic death of hypertrophic chondrocytes associated with an endemic osteoarthritis.

3. LncRNA MIAT regulated by selenium and T-2 toxin increases NF-κB-p65 activation, promoting the progress of Kashin-Beck Disease.

4. ADAMTS4 and ADAMTS5 may be considered as new molecular therapeutic targets for cartilage damages with Kashin-Beck Disease.

5. Conservative tibiotalocalcaneal fusion for partial talar avascular necrosis in conjunction with ankle and subtalar joint osteoarthritis in Kashin-Beck disease: A case report.

6. [The Effect of Disordered Glycometabolism of Kashin-Beck Disease on the Function of Chondrocytes].

7. The characteristics of positive and confusing hand X-ray signs in diagnosing Kashin-Beck Disease in children in China.

8. Reliability and validity of the 12-item WHODAS 2.0 in patients with Kashin-Beck disease.

9. Increased Chondrocyte Apoptosis in Kashin-Beck Disease and Rats Induced by T-2 Toxin and Selenium Deficiency.

10. The arthropathic and functional impairment features of adult Kashin-Beck disease patients in Aba Tibetan area in China.

11. Oxidative stress and status of antioxidant enzymes in children with Kashin-Beck disease.

12. An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin.

13. Clinical features of Kashin-Beck disease in adults younger than 50 years of age during a low incidence period: severe elbow and knee lesions.

14. Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin-Beck disease using T-2 toxin and selenium deficiency conditions.

15. Pathways related to mitochondrial dysfunction in cartilage of endemic osteoarthritis patients in China.

16. Oxidant damage in Kashin-Beck disease and a rat Kashin-Beck disease model by employing T-2 toxin treatment under selenium deficient conditions.

17. Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.

18. A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee.

19. Development and validation of a quality of life instrument for Kashin-Beck disease: an endemic osteoarthritis in China.

20. Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients.

21. Kashin Beck Disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation.

22. Measuring health-related quality of life in Kashin-Beck disease using EQ-5D.

23. Selenium in human health and disease.

24. The effect of Kashin-Beck disease-affected feed and T-2 toxin on the bone development of Wistar rats.

Catalog

Books, media, physical & digital resources